To access this material please log in or register

Register Authorize

Hypertrophic cardiomyopathy and arterial hypertension: is a combination possible?

Krylova N. S.1, Khashieva F. M.1, Demkina A. E.1, Kovalevskaya E. A.2, Poteshkina N. G.1
1 - State Budgetary Educational Institution of Higher Professional Education "N. I. Pirogov Russian National Research Medical University" of the RF Ministry of Health Care, Ostrovityanova 1, Moscow 117997
2 - State Budgetary Institution of Health Care, "Municipal Clinical Hospital #52 of the Moscow Department of Health Care", Pekhotnaya 3, Moscow 123182

Keywords: hyperpiesis, hypertrophic cardiomyopathy, myocardial hypertrophy, differential diagnosis

DOI: 10.18087/rhj.2015.3.2086

For many years, HCMP has been considered a disease of young people at a high risk of sudden cardiac death. This idea was due to common presentation of patients with severe HCMP and pronounced clinical symptoms. Most of such patients had normal or reduced BP. For this reason, it has been assumed for a long time that only arterial hypotension was characteristic of HCMP. After implementation of EchoCG in clinical practice, it was found that this disease may be asymptomatic or have moderate clinical manifestations, and can be diagnosed accidentally during an annual examination. Multiple modern studies have shown that patients with HCMP can survive through elderly and senile age, when they develop comorbidity, specifically AH. At present, the most of specialists acknowledge a possibility of combined HCMP and AH.
  1. Gersh BJ, Maron BJ, Bonow RO et al. 2011 ACCF / AHA Guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation / American Heart Association Task Force on Practice Guidelines. Circulation. 2011 Dec 13;124 (24):e783–831.
  2. Maron BJ, Towbin JA, Thiene G et al. Contemporary definitions and classification of the cardiomyopathies: an AHA Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006 Apr 11;113 (14):1807–16.
  3. Elliott PM, Anastasakis A, Borger MA et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014 Oct 14;35 (39):2733–79.
  4. Elliott P, Andersson B, Arbustini E et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology working group on myocardial and pericardial diseases. Eur Heart J. 2008 Jan;29 (2):270–6.
  5. Агеев Ф. Т., Габрусенко С. А., Постнов А. Ю. и др. Клинические рекомендации по диагностике и лечению кардиомиопатий (гипертрофическая). Евразийский кардиологический журнал. 2014;3:5–23.
  6. Беленков Ю. Н., Привалова Е. В., Каплунова В. Ю. Гипертро­фическая кардиомиопатия: руководство для врачей. – М.: «ГЭОТАР-Медиа», 2011. – 392с.
  7. Force T, Bonow RO, Houser SR et al. Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute. Circulation. 2010 Sep 14;122 (11):1130–3.
  8. Tian T, Liu Y, Zhou X, Song L. Progress in the molecular genetics of hypertrophic cardiomyopathy: a mini-review. Gerontology. 2013;59 (3):199–205.
  9. Kassem HSh, Azer RS, Saber-Ayad M et al. Early results of sarcomeric gene screening from the Egyptian National BA-HCM Program. J Cardiovasc Transl Res. 2013 Feb;6 (1):65–80.
  10. McKenna WJ, Deanfield JE. Hypertrophic cardiomyopathy: an important cause of sudden death. Arch Dis Child. 1984 Oct;59 (10):971–5.
  11. Fiddler GI, Tajik AJ, Weidman W et al. Idiopathic hypertrophic subaortic stenosis in the young. Am J Cardiol. 1978 Nov;42 (5):793–9.
  12. Maron BJ, Roberts WC, Edwards JE et al. Sudden death in patients with hypertrophic cardiomyopathy: characterization of 26 patients with functional limitation. Am J Cardiol. 1978 May 1;41 (5):803–10.
  13. Kubo T, Kitaoka H, Okawa M et al. Hypertrophic cardiomyopathy in the elderly. Geriatr Gerontol Int. 2010 Jan;10 (1):9–16.
  14. Bonow RO, Mann DL, Ziper DP, Libby P. Braunwald’s Heart disease. A textbook of cardiovascular medicine. Single volume, ninth edition. – Elsevier, 2012. – 2048p.
  15. 2013 European Society of Hypertension-European Society of Cardio­logy guidelines for the management of arterial hypertension. Russ J Cardiol. 2014;1 (105):7–94.
  16. Mancia G, Fagard R, Narkiewicz K et al. 2013 ESH / ESC Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013 Jul;31 (7):1281–357.
  17. Якушин С. С. Гипертрофическая кардиомиопатия и сочетанная патология. Труды XIII Российского национального конгресса «Человек и лекарство». – М., 2006. – c 47–52.
  18. Kato TS, Noda A, Izawa H et al. Discrimination of nonobstructive hypertrophic cardiomyopathy from hypertensive left ventricular hypertrophy on the basic of strain rate imaging by tissue Doppler ultrasonography. Circulation. 2004 Dec 21;110 (25):3808–14.
  19. Караулова Ю. Л. Гипертрофия левого желудочка при артериальной гипертонии и гипертрофической кардиомиопатии: детерминанты эволюции, оптимизация методов диагностики и лечения, динамика на фоне длительной медикаментозной терапии. Автореф. дис. … канд. мед. наук. – М., 2009. – 39с.
  20. Крылова Н. С., Крылов А. Л., Потешкина Н. Г. Дифференциальная диагностика гипертрофической кардиомиопатии и гипертонического сердца с помощью тестов с физической нагрузкой. Российский кардиологический журнал. 2014;5 (109):29–34.
  21. Aslam F, Haque A, Foody J, Shirani J. The frequency and functional impact of overlapping hypertension on hypertrophic cardiomyopathy: a single-center experience. J Clin Hypertens (Greenwich). 2010 Apr;12 (4):240–5.
  22. Pai RV, Hegde HV, Santhosh M et al. Bilateral brachial plexus blocks in a patient of hypertrophic obstructive cardiomyopathy with hypertensive crisis. Indian J Anaesth. 2013 Jan;57 (1):72–5.
  23. Olivotto I, Maron BJ, Tomberli B et al. Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2013 Jul 30;62 (5):449–57.
  24. Гладышева Е. П. Сравнительное изучение особенностей структурно-функционального состояния сердца при гипертрофической кардиомиопатии, гипертонической болезни, ишемической болезни сердца и «спортивном сердце». Автореф. дис…. канд. мед. наук. – Челябинск, 2005. – 22 с.
Krylova N. S., Khashieva F. M., Demkina A. E. et al. Hypertrophic cardiomyopathy and arterial hypertension: is a combination possible? Russian Heart Journal. 2015;14 (3):164–169

To access this material please log in or register

Register Authorize
Ru En